Pharmaxis is a new biotechnology company based in Sydney, Australia. Sheds light on the important stages in the development and commercialization of the company's solutions are facing. Major and some unique solutions, management team and their understanding of the industry, and stresses that a good decision point can overcome the obvious obstacles to growth. The company is now at a key point solutions. It must determine the best approach to the commercialization of its first diagnostic product. The wrong decision can waste scarce financial resources, divert time managers and researchers, and threaten the reputation of the company to potential investors. "Hide
by Deepak Sardana, Don Scott-Kemmis Source: Richard Ivey School of Business Foundation 13 pages. Publication Date: October 17, 2006. Prod. #: 906M93-PDF-ENG
Related Case Solutions & Analyses:
Where Have You Been: An Exercise to Assess Your Exposure to the Rest of the Worlds Peoples
One CEOs Trip From Dismissive to Convinced
Human Resources Management: Challenges for Graduate Education
Strategic Transformation as the Essential Last Step in the Process of Business Turnaround
Stanford Graduate School of Business
Challenge of Change: Note
Air Products and Chemicals Inc.: MIS Reorganization (B)
The Chattanooga Ice Cream Division
Expatica Communications: Leading through Tragedy
Cervus Equipment Corporation: Diversified Growth in Trucking
